Bay Street News, March 7th, 2024

Highlights: Immuron proceeding to Phase 3 registration strategy with the FDA Travelan® topline clinical trial results demonstrate protective efficacy with […]

Fourth quarter Net Sales increased 1.6% year-over-year to $245.6 million; diluted EPS of $0.21 Women’s business grew double digits in […]

LONDON, March 07, 2024 (GLOBE NEWSWIRE) — Retailers are optimistic about their prospects and the future of physical stores. But […]

SHANGHAI, China, March 07, 2024 (GLOBE NEWSWIRE) — Bilibili Inc. (“Bilibili” or the “Company”) (NASDAQ: BILI and HKEX: 9626), an […]

BEIJING, March 07, 2024 (GLOBE NEWSWIRE) — QuantaSing Group Limited (NASDAQ: QSG) (“QuantaSing” or the “Company”), a leading online learning […]

SHENZHEN, China, March 07, 2024 (GLOBE NEWSWIRE) — Huize Holding Limited, (“Huize”, the “Company” or “we”) (NASDAQ: HUIZ), a leading […]

TORONTO, March 07, 2024 (GLOBE NEWSWIRE) — Dundee Precious Metals Inc. (TSX: DPM) (“DPM” or “the Company”) today announced that […]

GUANGZHOU, China, March 07, 2024 (GLOBE NEWSWIRE) — FANHUA Inc. (“FANHUA” or the “Company”) (Nasdaq: FANH), a leading independent financial […]

SAN JOSE, Calif., March 07, 2024 (GLOBE NEWSWIRE) — Synaptics® Incorporated (Nasdaq: SYNA) today announced the appointment of Lisa Bodensteiner […]

SHENZHEN, China, March 07, 2024 (GLOBE NEWSWIRE) — Aurora Mobile Limited (NASDAQ: JG) (“Aurora Mobile” or the “Company”), a leading […]